相关实验视频
Updated: Jun 13, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
COL12A1通过FAK/PI3K/AKT/mTOR路径促进骨肉瘤的进展
Yun-Pu Zhang1, Hai-Xia Wang1, Zhi-Chao Gao1
1Department of Spine Surgery, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, P.R.China.
原体12型α1链 (COL1A1) 通过激活FAK/PI3K/AKT/mTOR通路,促进骨髓瘤 (OS) 的生长,转移和化学抵抗. COL1A1可以作为OS患者的预测生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 骨肉瘤 (OS) 是一种流行的儿科癌症,具有高转移潜力和耐治疗性.
- COL12A1在癌症中经常过度表达,并与预后不佳有关.
研究的目的:
- 为了研究COL12A1在骨髓瘤进展中的作用.
- 阐明COL12A1在OS中的作用的基础分子机制.
主要方法:
- 生物信息学分析,临床样本检查和OS细胞系研究.
- 功能性检测包括透孔,CCK-8,流细胞计和伤口愈合.
- 西部斑点分析以评估FAK/PI3K/AKT/mTOR路径.
主要成果:
- 在OS组织和细胞中,COL12A1的表达显著上调.
- COL12A1的过度表达增强了OS细胞的增殖,迁移,入侵和细胞周期的进展,同时抑制了细胞亡.
- COL12A1激活了FAK/PI3K/AKT/mTOR通路,并且抑制FAK (Y15) 逆转了这些影响.
结论:
- COL12A1通过FAK/PI3K/AKT/mTOR通路促进骨肉瘤的发展.
- COL12A1代表了预测和识别OS患者的潜在生物标志物.
更多相关视频
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation